<DOC>
	<DOCNO>NCT02039024</DOCNO>
	<brief_summary>The primary objective protocol investigate monoaminergic ( dopamine、serotonin、and norepinephrine ) nervous system amyloid deposition Parkinson 's disease patient non-motor symptom ( focus impulse control disorder dementia ) novel 18F-DTBZ Florbetapir F-18 PET image . This study compare amyloid deposition brain florbetapir F-18 PET image monoaminergic function by18F- DTBZ PET NC group , PD group , PDD group , AD group . Investigators also analyze monoaminergic function by18F- DTBZ PET PDI group .</brief_summary>
	<brief_title>Imaging Non-motor Symptoms Parkinson 's Disease Novel 18F-DTBZ Florbetapir F-18 PET</brief_title>
	<detailed_description>Study duration expect completed period 3 year . This study compare amyloid deposition brain florbetapir F-18 PET image monoaminergic function by18F- DTBZ PET 10 age-matched healthy subject ( NC group ) , 30 PD patient without dementia/ICD ( PD group ) , 30 PD patient dementia ( PDD group ) , 20 patient dementia ( AD group ) . We also analyze monoaminergic function by18F- DTBZ PET 30 PD patient ICD ( PDI group ) . Each evaluable subject involve study must fulfill inclusion exclusion criterion accord subject grouping , healthy subject , PD , PDD , AD patient 4 visit study , one screening visit , one florbetapir F-18 imaging visit , one 18F-DTBZ image visit , one safety evaluation.PDI patient 3 visit study , one screening visit , one 18F-DTBZ image visit , one safety evaluation . Safety measurement evaluate medical history , vital sign , physical examination , laboratory examination collect adverse event .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>1.10 healthy subject : . Male female subject , age range 20~80 . ii . Subjects know neurological psychiatric disease . However , mild peripheral neuropathy , entrapment syndrome sciatica allowed.iii . Subjects provide write informed consent prior study entry . 2.30 subject diagnosis PD : . Male female patient , age range 20~80 . ii . Patients fulfil `` UK Parkinson 's Disease Society Brain Bank Clinical Diagnostic Criteria '' `` PD '' . ( Appendix I ) .iii . Patients clinical evidence dementia ICD . iv . Patients provide write informed consent prior study entry . If patient incapable informed consent , caregiver may consent behalf patient ( patient must still confirm assent ) . 3.30 subject diagnosis PD dementia : . Male female patient , age range 20~80.ii . Patients fulfil `` Movement Disorders Society diagnostic criterion PDD `` possible '' `` probable '' PDD ( Emre , 2006 ) . ( Appendix II ) iii . Patients provide write informed consent prior study entry . If patient incapable informed consent , caregiver may consent behalf patient ( patient must still confirm assent ) .iv . Patients provide write informed consent prior study entry . If patient incapable informed consent , caregiver may consent behalf patient ( patient must still confirm assent ) . 4.20 subject diagnosis AD : . Male female patient , age range 20~80 . ii . Patients fulfil `` DSMIVTR Diagnostic criterion Alzheimer 's Disease '' AD . ( Appendix III ) .iii . Patients provide write informed consent prior study entry . If patient incapable informed consent , caregiver may consent behalf patient ( patient must still confirm assent ) .iv . Patients provide write informed consent prior study entry . If patient incapable informed consent , caregiver may consent behalf patient ( patient must still confirm assent ) . 5.30 subject diagnosis PD ICD : . Male female patient , age range 20~80 . ii . Patients fulfil one diagnostic criterion definition ICDs : pathological gambling , hypersexuality , compulsive shopping , compulsive eating , punding , compulsive medication use ( Voon , 2009 ) . ( Appendix IV ) .iii . Patients provide write informed consent prior study entry . If patient incapable informed consent , caregiver may consent behalf patient ( patient must still confirm assent ) .iv . Patients provide write informed consent prior study entry . If patient incapable informed consent , caregiver may consent behalf patient ( patient must still confirm assent ) . 1 . Pregnant become pregnant study ( documented pregnancy test screen date study accord PI discretion ) current breast feeding . 2 . Any subject clinically significant abnormal laboratory value , and/or clinically significant unstable medical psychiatric illness . 3 . History drug alcohol abuse within last year , prior prolonged history abuse . 4 . History intracranial operation , include thalamotomy , pallidotomy , and/or deep brain stimulation . 5 . Any documented abnormality brain CT MRI brain , might contribute motor function , hydrocephalus , multiple infarction encephalomalacia , exclude . Mild cortical atrophy nonspecific white matter change allow . 6 . Any evidence secondary parkinsonism ( multiple infarct , intoxication , hydrocephalus , etc ) neurodegenerative disease ( multiple system atrophy , progressive supranuclear palsy ) . 7 . History allergy radioligands contain 18F isotope .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>18F-DTBZ</keyword>
</DOC>